Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to provide accessible scientific evidence to help ensure public confidence in food safety and environmental policy when new chemical additives are introduced.

Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)

All food and feed additives permitted for use in the United Kingdom must undergo a comprehensive, evidence‑based safety assessment before approval. This process evaluates potential risks and ensures additives can only be used in specified food categories, at controlled levels, and with any necessary labelling requirements.

The Food Standards Agency (FSA) is responsible for assessing and authorising new additives and for reviewing changes to existing approvals. To support transparency and public confidence, the FSA publishes its scientific risk assessments and consults publicly on proposed authorisations so that stakeholders and consumers can provide their views before decisions are made.

Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, when she is scheduled to next meet representatives from the Sikh Federation to discuss the detention of Jagtar Singh Johal.

Answered by Seema Malhotra - Parliamentary Under-Secretary (Foreign, Commonwealth and Development Office)

I refer the Hon Member to the answer he received on 9 February in response to Question 108102.

Question to the Home Office:

To ask the Secretary of State for the Home Department, whether she will publish the material her Department disclosed to the courts and the Independent Reviewer of Terrorism Legislation on Palestine Action.

Answered by Dan Jarvis - Minister of State (Cabinet Office)

The material relied upon by the Court in its decision making is referenced throughout the judgment which is publicly available. R (Ammori) v SSHD OPEN Judgment (final)

The open material referred to during the proceedings can be requested from the court in accordance with the Civil Rules on Court documents. PART 5 – COURT DOCUMENTS – Civil Procedure Rules – Justice UK. Any material submitted in closed proceedings is protected by the Justice and Security Act 2013 and will not be disclosed for reasons of national security.

The Independent Reviewer of Terrorism Legislation has access to secret and sensitive national security information in order to carry out his role. He routinely publishes his findings in reports that are available on his website: https://terrorismlegislationreviewer.independent.gov.uk/

Question to the Home Office:

To ask the Secretary of State for the Home Department, with reference to her comments to the BBC on 11 August 2025, whether her Department presented information to the courts during legal proceedings relating to the proscription of Palestine Action on people who are objecting to that proscription because they don't know the full nature of the organisation as a result of court restrictions on reporting while serious prosecutions are under way; and if she will publish this information.

Answered by Dan Jarvis - Minister of State (Cabinet Office)

The material relied upon by the Court in its decision making is referenced throughout the judgment which is publicly available here: R (Ammori) v SSHD OPEN Judgment (final)

The open material referred to during the proceedings can be requested from the court in accordance with the Civil Procedure Rules on Court documents see: PART 5 – COURT DOCUMENTS – Civil Procedure Rules – Justice UK. Any material submitted in closed proceedings is protected by the Justice and Security Act 2013 and will not be disclosed for reasons of national security. It would not be appropriate to comment further during ongoing legal proceedings.

The Independent Reviewer of Terrorism Legislation has access to secret and sensitive national security information in order to carry out his role. He routinely publishes his findings in reports that are available on his website: https://terrorismlegislationreviewer.independent.gov.uk/

Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, what assessment his Department has made of the adequacy of current risk modelling for frontier AI systems.

Answered by Kanishka Narayan - Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)

The AI Security Institute was established to deepen our understanding of frontier AI risks.

The Institute works with the national security community and government experts to ensure AI technology delivers on its potential for UK growth, while working with companies to assess and manage the potential risks this technology poses.

The Institute’s role is also to ensure AI risk evaluation and understanding is more scientifically rigorous and reliable.

Advancing the scientific field of AI safety will help the UK ensure it has the best evidence available to navigate the uncertain trajectories that advanced AI could take.

Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, what information her Department holds on the Artificial Intelligence Security Institute assessment of xAI's Grok.

Answered by Kanishka Narayan - Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)

The AI Security Institute collaborates with leading AI developers to measure the capabilities of advanced AI and recommend risk mitigations, to ensure we stay ahead of possible AI impacts.

The Government does not give a running commentary on models being tested or which models we have been granted access to due to commercial and security sensitivities.

Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, what assessment she has made of the potential risks associated with advanced AI systems across government.

Answered by Kanishka Narayan - Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)

This government is taking a long‑term, science‑led approach to understanding and preparing for emerging AI risks, including the possibility of very rapid progress with transformative impacts on society and national security.

Through close collaboration with industry and international allies, the government has deepened its understanding of risks, improved AI model security, and built UK resilience against threats.

The Government’s National Security Strategy sets out our intent to build the UK national security agenda for AI and other frontier technologies. This agenda will support the development of the UK's AI-enabled defence and security capabilities.

This is complimented by the work of the AI Security Institute (AISI), which focuses on emerging AI risks with serious security implications, including cyber misuse, chemical or biological risks, and autonomous AI capabilities.

The Government will remain vigilant and prepare for new AI risks, including rapid advancements that could affect society and national security.

Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, what steps he is taking to help improve transparency on departmental responsibility for AI risk.

Answered by Kanishka Narayan - Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)

This government is taking a long‑term, science‑led approach to understanding and preparing for emerging AI risks, including the possibility of very rapid progress with transformative impacts on society and national security.

Through close collaboration with industry and international allies, the government has deepened its understanding of risks, improved AI model security, and built UK resilience against threats.

The Government’s National Security Strategy sets out our intent to build the UK national security agenda for AI and other frontier technologies. This agenda will support the development of the UK's AI-enabled defence and security capabilities.

This is complimented by the work of the AI Security Institute (AISI), which focuses on emerging AI risks with serious security implications, including cyber misuse, chemical or biological risks, and autonomous AI capabilities.

The Government will remain vigilant and prepare for new AI risks, including rapid advancements that could affect society and national security.

Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, whether he plans to publish an AI Security Strategy.

Answered by Kanishka Narayan - Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)

This government is taking a long‑term, science‑led approach to understanding and preparing for emerging AI risks, including the possibility of very rapid progress with transformative impacts on society and national security.

Through close collaboration with industry and international allies, the government has deepened its understanding of risks, improved AI model security, and built UK resilience against threats.

The Government’s National Security Strategy sets out our intent to build the UK national security agenda for AI and other frontier technologies. This agenda will support the development of the UK's AI-enabled defence and security capabilities.

This is complimented by the work of the AI Security Institute (AISI), which focuses on emerging AI risks with serious security implications, including cyber misuse, chemical or biological risks, and autonomous AI capabilities.

The Government will remain vigilant and prepare for new AI risks, including rapid advancements that could affect society and national security.

Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, what emergency powers the Government holds to direct private AI developers during a national security incident involving advanced AI systems.

Answered by Kanishka Narayan - Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)

This government is taking a long‑term, science‑led approach to understanding and preparing for emerging AI risks, including the possibility of very rapid progress with transformative impacts on society and national security.

Through close collaboration with industry and international allies, the government has deepened its understanding of risks, improved AI model security, and built UK resilience against threats.

The Government’s National Security Strategy sets out our intent to build the UK national security agenda for AI and other frontier technologies. This agenda will support the development of the UK's AI-enabled defence and security capabilities.

This is complimented by the work of the AI Security Institute (AISI), which focuses on emerging AI risks with serious security implications, including cyber misuse, chemical or biological risks, and autonomous AI capabilities.

The Government will remain vigilant and prepare for new AI risks, including rapid advancements that could affect society and national security.

Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, what protocols are in place to help ensure rapid information-sharing with AI companies during a national AI emergency.

Answered by Kanishka Narayan - Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)

This government is taking a long‑term, science‑led approach to understanding and preparing for emerging AI risks, including the possibility of very rapid progress with transformative impacts on society and national security.

Through close collaboration with industry and international allies, the government has deepened its understanding of risks, improved AI model security, and built UK resilience against threats.

The Government’s National Security Strategy sets out our intent to build the UK national security agenda for AI and other frontier technologies. This agenda will support the development of the UK's AI-enabled defence and security capabilities.

This is complimented by the work of the AI Security Institute (AISI), which focuses on emerging AI risks with serious security implications, including cyber misuse, chemical or biological risks, and autonomous AI capabilities.

The Government will remain vigilant and prepare for new AI risks, including rapid advancements that could affect society and national security.

Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, what role the AI Safety Institute plays in national security preparedness for advanced AI systems.

Answered by Kanishka Narayan - Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)

This government is taking a long‑term, science‑led approach to understanding and preparing for emerging AI risks, including the possibility of very rapid progress with transformative impacts on society and national security.

Through close collaboration with industry and international allies, the government has deepened its understanding of risks, improved AI model security, and built UK resilience against threats.

The Government’s National Security Strategy sets out our intent to build the UK national security agenda for AI and other frontier technologies. This agenda will support the development of the UK's AI-enabled defence and security capabilities.

This is complimented by the work of the AI Security Institute (AISI), which focuses on emerging AI risks with serious security implications, including cyber misuse, chemical or biological risks, and autonomous AI capabilities.

The Government will remain vigilant and prepare for new AI risks, including rapid advancements that could affect society and national security.

Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, what role the AI Security Institute plays in national security preparedness for advanced AI systems.

Answered by Kanishka Narayan - Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)

This government is taking a long‑term, science‑led approach to understanding and preparing for emerging AI risks, including the possibility of very rapid progress with transformative impacts on society and national security.

Through close collaboration with industry and international allies, the government has deepened its understanding of risks, improved AI model security, and built UK resilience against threats.

The Government’s National Security Strategy sets out our intent to build the UK national security agenda for AI and other frontier technologies. This agenda will support the development of the UK's AI-enabled defence and security capabilities.

This is complimented by the work of the AI Security Institute (AISI), which focuses on emerging AI risks with serious security implications, including cyber misuse, chemical or biological risks, and autonomous AI capabilities.

The Government will remain vigilant and prepare for new AI risks, including rapid advancements that could affect society and national security.

Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, whether he will make an assessment of the potential merits of legislative powers of direction over AI developers in the event of a loss-of-control incident.

Answered by Kanishka Narayan - Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)

AI models have the potential to pose novel risks by behaving in unintended or unforeseen ways. The possibility that this behaviour could lead to loss of control over advanced AI systems is taken seriously by many experts.

The AI Security Institute (AISI) is researching the development of AI capabilities that could contribute towards AI’s ability to evade human control, as well the propensity of models to engage in misaligned actions.

Furthermore, through the Alignment Project – a funding consortium distributing up to £27m for research projects – AISI is supporting further foundational research into methods to develop AI systems that operate according to our goals, without unintended or harmful behaviours.

The Government has been clear that we will legislate on AI where needed but we will do so on the basis of evidence where any serious gaps exist.

Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, what (a) short, (b) medium (c) and long-term actions he is taking to help anticipate and mitigate the potential risks of AI loss-of-control.

Answered by Kanishka Narayan - Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)

AI models have the potential to pose novel risks by behaving in unintended or unforeseen ways. The possibility that this behaviour could lead to loss of control over advanced AI systems is taken seriously by many experts.

The AI Security Institute (AISI) is researching the development of AI capabilities that could contribute towards AI’s ability to evade human control, as well the propensity of models to engage in misaligned actions.

Furthermore, through the Alignment Project – a funding consortium distributing up to £27m for research projects – AISI is supporting further foundational research into methods to develop AI systems that operate according to our goals, without unintended or harmful behaviours.

The Government has been clear that we will legislate on AI where needed but we will do so on the basis of evidence where any serious gaps exist.

Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, whether his Department has undertaken scenario planning exercises for AI loss-of-control events.

Answered by Kanishka Narayan - Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)

AI models have the potential to pose novel risks by behaving in unintended or unforeseen ways. The possibility that this behaviour could lead to loss of control over advanced AI systems is taken seriously by many experts.

The AI Security Institute (AISI) is researching the development of AI capabilities that could contribute towards AI’s ability to evade human control, as well the propensity of models to engage in misaligned actions.

Furthermore, through the Alignment Project – a funding consortium distributing up to £27m for research projects – AISI is supporting further foundational research into methods to develop AI systems that operate according to our goals, without unintended or harmful behaviours.

The Government has been clear that we will legislate on AI where needed but we will do so on the basis of evidence where any serious gaps exist.

Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, what mechanisms are in place to coordinate cross-government preparedness for AI loss-of-control scenarios.

Answered by Kanishka Narayan - Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)

AI models have the potential to pose novel risks by behaving in unintended or unforeseen ways. The possibility that this behaviour could lead to loss of control over advanced AI systems is taken seriously by many experts.

The AI Security Institute (AISI) is researching the development of AI capabilities that could contribute towards AI’s ability to evade human control, as well the propensity of models to engage in misaligned actions.

Furthermore, through the Alignment Project – a funding consortium distributing up to £27m for research projects – AISI is supporting further foundational research into methods to develop AI systems that operate according to our goals, without unintended or harmful behaviours.

The Government has been clear that we will legislate on AI where needed but we will do so on the basis of evidence where any serious gaps exist.

Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, how her Department defines AI loss of control; and whether that definition is shared across Departments.

Answered by Kanishka Narayan - Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)

AI models have the potential to pose novel risks by behaving in unintended or unforeseen ways. The possibility that this behaviour could lead to loss of control over advanced AI systems is taken seriously by many experts.

The AI Security Institute (AISI) is researching the development of AI capabilities that could contribute towards AI’s ability to evade human control, as well the propensity of models to engage in misaligned actions.

Furthermore, through the Alignment Project – a funding consortium distributing up to £27m for research projects – AISI is supporting further foundational research into methods to develop AI systems that operate according to our goals, without unintended or harmful behaviours.

The Government has been clear that we will legislate on AI where needed but we will do so on the basis of evidence where any serious gaps exist.

Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, whether his Department has been designated as the lead department for AI loss-of-control risks.

Answered by Kanishka Narayan - Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)

AI models have the potential to pose novel risks by behaving in unintended or unforeseen ways. The possibility that this behaviour could lead to loss of control over advanced AI systems is taken seriously by many experts.

The AI Security Institute (AISI) is researching the development of AI capabilities that could contribute towards AI’s ability to evade human control, as well the propensity of models to engage in misaligned actions.

Furthermore, through the Alignment Project – a funding consortium distributing up to £27m for research projects – AISI is supporting further foundational research into methods to develop AI systems that operate according to our goals, without unintended or harmful behaviours.

The Government has been clear that we will legislate on AI where needed but we will do so on the basis of evidence where any serious gaps exist.

Question to the Department for Work and Pensions:

To ask the Secretary of State for Work and Pensions, with reference to the Parliamentary and Health Service Ombudsman report on changes to women's State Pension age, published on 21 March 2024, if he will make an estimate of the cost of providing compensation to impacted women in Dewsbury & Batley; and if he will consider the potential mechanisms for doing so.

Answered by Torsten Bell - Parliamentary Secretary (HM Treasury)

The Government has made its decision on this case based on due process and careful consideration of the body of evidence. We have decided it would not be appropriate to pay compensation and the detailed reasons for this decision have been placed in the House library.

Question to the Cabinet Office:

To ask the Minister for the Cabinet Office, what discussions the Prime Minister had with the then-UK Ambassador to the US on visiting Palantir head offices in Washington DC in February 2025.

Answered by Nick Thomas-Symonds - Paymaster General and Minister for the Cabinet Office

I refer the Hon Member to my answer of 10th March 2026, Official Report, PQ 112839.

Question to the Cabinet Office:

To ask the Minister for the Cabinet Office, what was the purpose of the Prime Minister's visit to Palantir head offices in Washington DC in February 2025.

Answered by Nick Thomas-Symonds - Paymaster General and Minister for the Cabinet Office

I refer the Hon Member to my answer of 10th March 2026, Official Report, PQ 112839.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential impact of US-UK trade agreements on (a) drug prices and (b) levels of excess deaths in the NHS.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

Costs of the United States and United Kingdom pharmaceuticals trade deal will start smaller but will increase over time as the National Institute for Health and Care Excellence (NICE) approves more medicines. Total costs over the spending review period are expected to be approximately £1 billion. However, the final costs will depend on which medicines NICE decides to approve and the actual uptake.

We have no plans to publish an impact assessment for the deal. Innovative medicines are critical to the future success and sustainability of the National Health Service. It is only by harnessing the power of new technologies that we can transform the lives of patients with currently untreatable conditions. Medicines are more than just a cost, bringing major societal and economic benefits, helping people stay in work, reducing pressure on public services, or giving patients a second chance at life.

The deal will be funded by allocations made at the Spending Review, where record funding for the NHS was secured. Future funding will be settled at the next Spending Review.

Ministerial meetings with external stakeholders are routinely published quarterly on the GOV.UK website in arrears. Officials from the Department have engaged extensively with patient groups, pharmaceutical companies and trade bodies. The Government has committed to working with industry in the coming months on the future of medicines pricing and will also engage patient groups in this process.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he plans to provide extra resource to the NHS to offset changes to drug prices under US-UK trade agreements.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

Costs of the United States and United Kingdom pharmaceuticals trade deal will start smaller but will increase over time as the National Institute for Health and Care Excellence (NICE) approves more medicines. Total costs over the spending review period are expected to be approximately £1 billion. However, the final costs will depend on which medicines NICE decides to approve and the actual uptake.

We have no plans to publish an impact assessment for the deal. Innovative medicines are critical to the future success and sustainability of the National Health Service. It is only by harnessing the power of new technologies that we can transform the lives of patients with currently untreatable conditions. Medicines are more than just a cost, bringing major societal and economic benefits, helping people stay in work, reducing pressure on public services, or giving patients a second chance at life.

The deal will be funded by allocations made at the Spending Review, where record funding for the NHS was secured. Future funding will be settled at the next Spending Review.

Ministerial meetings with external stakeholders are routinely published quarterly on the GOV.UK website in arrears. Officials from the Department have engaged extensively with patient groups, pharmaceutical companies and trade bodies. The Government has committed to working with industry in the coming months on the future of medicines pricing and will also engage patient groups in this process.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what discussions he has held with a) Pharmaceutical companies, b) Pharmaceutical industry groups and c) patient groups and charities on the US-UK Pharmaceuticals deal.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

Costs of the United States and United Kingdom pharmaceuticals trade deal will start smaller but will increase over time as the National Institute for Health and Care Excellence (NICE) approves more medicines. Total costs over the spending review period are expected to be approximately £1 billion. However, the final costs will depend on which medicines NICE decides to approve and the actual uptake.

We have no plans to publish an impact assessment for the deal. Innovative medicines are critical to the future success and sustainability of the National Health Service. It is only by harnessing the power of new technologies that we can transform the lives of patients with currently untreatable conditions. Medicines are more than just a cost, bringing major societal and economic benefits, helping people stay in work, reducing pressure on public services, or giving patients a second chance at life.

The deal will be funded by allocations made at the Spending Review, where record funding for the NHS was secured. Future funding will be settled at the next Spending Review.

Ministerial meetings with external stakeholders are routinely published quarterly on the GOV.UK website in arrears. Officials from the Department have engaged extensively with patient groups, pharmaceutical companies and trade bodies. The Government has committed to working with industry in the coming months on the future of medicines pricing and will also engage patient groups in this process.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether his Department plans to publish an impact assessment for the US-UK Pharmaceuticals deal.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

Costs of the United States and United Kingdom pharmaceuticals trade deal will start smaller but will increase over time as the National Institute for Health and Care Excellence (NICE) approves more medicines. Total costs over the spending review period are expected to be approximately £1 billion. However, the final costs will depend on which medicines NICE decides to approve and the actual uptake.

We have no plans to publish an impact assessment for the deal. Innovative medicines are critical to the future success and sustainability of the National Health Service. It is only by harnessing the power of new technologies that we can transform the lives of patients with currently untreatable conditions. Medicines are more than just a cost, bringing major societal and economic benefits, helping people stay in work, reducing pressure on public services, or giving patients a second chance at life.

The deal will be funded by allocations made at the Spending Review, where record funding for the NHS was secured. Future funding will be settled at the next Spending Review.

Ministerial meetings with external stakeholders are routinely published quarterly on the GOV.UK website in arrears. Officials from the Department have engaged extensively with patient groups, pharmaceutical companies and trade bodies. The Government has committed to working with industry in the coming months on the future of medicines pricing and will also engage patient groups in this process.

Question to the HM Treasury:

To ask the Chancellor of the Exchequer, what advice or guidance her Department provides on compliance with sanctions imposed by the United States against judges, lawyers, and officials of the International Criminal Court to banks and firms providing financial services.

Answered by Lucy Rigby - Economic Secretary (HM Treasury)

The Government has not issued specific advice or guidance to banks or financial services firms on complying with United States sanctions imposed on individuals associated with the International Criminal Court.

The action taken by the United States under Executive Order 14203 is limited to the jurisdiction of the United States and does not reflect any legal action or domestic sanction taken by the UK.

The UK respects the independence of the International Criminal Court and does not support sanctioning individuals or organisations associated with the Court.

Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, whether legal, financial, diplomatic and technological support has been offered to UK nationals who have been sanctioned by the United States in relation to the International Criminal Court's investigation into war crimes in the State of Palestine.

Answered by Chris Elmore - Parliamentary Under-Secretary (Foreign, Commonwealth and Development Office)

The UK respects the independence of the International Criminal Court (ICC) and does not support sanctioning individuals or organisations associated with the Court. We are in touch with the ICC about this matter, and have also raised our concerns with the US Administration.

Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, if she will raise the case of imprisoned Palestinian Parliamentarian Marwan Barghouti with her Israeli counterparts, in the context of recent comments by the Inter-Parliamentary Union’s independent legal observer on the lack of fairness in Marwan Barghouti's trial.

Answered by Hamish Falconer - Parliamentary Under-Secretary (Foreign, Commonwealth and Development Office)

I refer the Hon Member to the answer given on 21 October 2025 in response to Question 80474.

Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, whether she has had discussions with her counterparts in Palestine and Israel on arranging a visit by her Department's officials to Marwan Barghouti.

Answered by Hamish Falconer - Parliamentary Under-Secretary (Foreign, Commonwealth and Development Office)

I refer the Hon Member to the answer given on 21 October 2025 in response to Question 80474.

Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, whether her Department has made representations to the Israeli Government on the detention of Marwan Barghouti, including allegations of torture.

Answered by Hamish Falconer - Parliamentary Under-Secretary (Foreign, Commonwealth and Development Office)

I refer the Hon Member to the answer given on 21 October 2025 in response to Question 80474.

Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what steps her department intends to take in response to the Israeli government's registration of occupied territory in the Palestinian West Bank as state property; and what assessment she has made of the potential implications for her policies of this move.

Answered by Hamish Falconer - Parliamentary Under-Secretary (Foreign, Commonwealth and Development Office)

I refer the Hon Member to my remarks in the Westminster Hall Debate on the Gaza Healthcare System on 24 February 2026.

Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what assessment she has made of the potential implications for her policies of reports alleging torture in Israeli prisons from the United Nations Special Rapporteur for Torture and the Palestinian Center for Human Rights.

Answered by Hamish Falconer - Parliamentary Under-Secretary (Foreign, Commonwealth and Development Office)

I refer the Hon Member to the answer given on 21 October 2025 in response to Question 80474.

Question to the Department for Environment, Food and Rural Affairs:

To ask the Secretary of State for Environment, Food and Rural Affairs, what assessment she has made of whether CEOs of water have enhanced their salaries through other means, such as additional payments and salary rises, in the context of her Department's ban of unfair bonuses.

Answered by Emma Hardy - Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)

On 5 November 2025, Ofwat published its 2024-25 Performance related executive pay (PRP) assessment, which confirmed more than £4 million of unfair bonuses were blocked for 2024-25.

The PRP assessment highlighted a lack of transparency around executive pay in the water sector. To address this, Ofwat has confirmed its intention to update the requirements for companies' annual regulatory reporting to require companies to publicly report in full the details of remuneration received by directors from the regulated, group and parent companies, including explanations of what the remuneration relates to. Ofwat will consult on these changes with the intention that it applies to company accounts for 2025-26.

The Government expects companies to abide by both the letter and spirit of the bonus rule.

Question to the Department for Environment, Food and Rural Affairs:

To ask the Secretary of State for Environment, Food and Rural Affairs, how much the proposed new water regulator will cost; who will pay these costs; and what assessment she has made of the potential for these costs to be passed onto consumers in the form of higher bills.

Answered by Emma Hardy - Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)

Across all our reforms the goal is to deliver our key outcomes – environment, customers, investability – in the most effective and efficient way possible to ensure lasting value.

Question to the Department for Environment, Food and Rural Affairs:

To ask the Secretary of State for Environment, Food and Rural Affairs, with reference to her Department's White Paper entitled A new vision for water, updated 19 February 2026, what assessment her Department has made of the potential impact of delaying fines to water companies on levels of compliance by water companies with the proposed regulatory regime.

Answered by Emma Hardy - Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)

Payment of fines is ultimately a matter for the regulator.

Closure of Al-Aqsa Mosque during Ramadan

Fipronil and Imidacloprid Pesticides

Royal Mail postal delivery services

King's Guard's ceremonial bearskin caps